跳至主要内容
临床试验/JPRN-UMIN000000599
JPRN-UMIN000000599已完成2 期

A phase II study of preoperative concurrent chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced non-small-cell lung cancer - A phase II study of preoperative concurrent chemoradiotherapy for non-small-cell lung cancer

Setouchi Lung Cancer Group0 个研究点目标入组 1 人开始时间: 2007年2月8日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
1

研究概览

简要总结

npublished

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • a) Malignant pleuritis or malignant pericarditis. b) Pleural dissemination. c) Positive suplra calavicle nodes. d) Active double cancer. The definition of inactive is that disease-free interval is more than 5 years. However, patients who have history of chemotherapy or thoracic irradiation are not acceptable. e) Patients with severe complications. 1) Pulmonary fibrosis recognized with computed tomography scanning. 2)Severe heart disease.(Uncontrollable angina or myocardial infarction within the past 3 months) 3) Uncontrollable Diabetes Mellitus. 4) Severe infectious disease 5) Other unsuitable patient judged by a physician. f) Women during pregnancy or lactating.

研究者

发起方
Setouchi Lung Cancer Group

相似试验